CorVel (CRVL) Competitors $110.39 +1.54 (+1.41%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CRVL vs. LH, DGX, DVA, CHE, AMED, MD, AMN, CCRN, ERIE, and RYANShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Erie Indemnity (ERIE), and Ryan Specialty (RYAN). CorVel vs. Laboratory Co. of America Quest Diagnostics DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Erie Indemnity Ryan Specialty Laboratory Co. of America (NYSE:LH) and CorVel (NASDAQ:CRVL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings. Which has more risk and volatility, LH or CRVL? Laboratory Co. of America has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, CorVel has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Is LH or CRVL more profitable? CorVel has a net margin of 9.64% compared to Laboratory Co. of America's net margin of 3.43%. CorVel's return on equity of 31.73% beat Laboratory Co. of America's return on equity.Company Net Margins Return on Equity Return on Assets Laboratory Co. of America3.43% 15.27% 7.13% CorVel 9.64%31.73%17.12% Do insiders and institutionals have more ownership in LH or CRVL? 95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 0.9% of Laboratory Co. of America shares are held by company insiders. Comparatively, 47.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better earnings and valuation, LH or CRVL? Laboratory Co. of America has higher revenue and earnings than CorVel. Laboratory Co. of America is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLaboratory Co. of America$12.16B1.68$418M$5.1747.27CorVel$795.31M7.13$76.25M$1.5770.31 Does the MarketBeat Community believe in LH or CRVL? Laboratory Co. of America received 427 more outperform votes than CorVel when rated by MarketBeat users. Likewise, 64.08% of users gave Laboratory Co. of America an outperform vote while only 63.79% of users gave CorVel an outperform vote. CompanyUnderperformOutperformLaboratory Co. of AmericaOutperform Votes61964.08% Underperform Votes34735.92% CorVelOutperform Votes19263.79% Underperform Votes10936.21% Do analysts rate LH or CRVL? Laboratory Co. of America currently has a consensus target price of $260.54, suggesting a potential upside of 6.61%. Given Laboratory Co. of America's stronger consensus rating and higher possible upside, analysts clearly believe Laboratory Co. of America is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Laboratory Co. of America 0 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.88CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor LH or CRVL? In the previous week, Laboratory Co. of America had 6 more articles in the media than CorVel. MarketBeat recorded 9 mentions for Laboratory Co. of America and 3 mentions for CorVel. Laboratory Co. of America's average media sentiment score of 1.41 beat CorVel's score of 0.94 indicating that Laboratory Co. of America is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Laboratory Co. of America 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryLaboratory Co. of America beats CorVel on 12 of the 19 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelInsurance agents, brokers, & service IndustryBusiness SectorNASDAQ ExchangeMarket Cap$5.67B$18.08B$7.48B$9.13BDividend YieldN/A1.37%2.23%4.00%P/E Ratio70.3125.9128.6717.53Price / Sales7.135.93101.4580.52Price / Cash54.4727.4829.2032.90Price / Book22.8614.876.144.69Net Income$76.25M$830.46M$136.63M$224.57M7 Day Performance0.19%3.82%3.30%3.33%1 Month Performance-4.21%-0.80%5.72%5.33%1 Year Performance41.68%18.58%24.67%22.97% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel2.2729 of 5 stars$110.39+1.4%N/A+41.7%$5.67B$795.31M70.314,870Upcoming EarningsLHLaboratory Co. of America4.853 of 5 stars$234.16+0.9%$260.54+11.3%+8.1%$19.58B$12.71B45.2975,500Positive NewsDGXQuest Diagnostics4.975 of 5 stars$153.89+1.4%$172.15+11.9%+15.1%$17.18B$9.54B20.6848,000Short Interest ↑Positive NewsDVADaVita3.9511 of 5 stars$157.06+2.4%$161.80+3.0%+62.2%$12.88B$12.67B16.9470,000CHEChemed4.9322 of 5 stars$530.55+1.7%$641.50+20.9%-5.9%$7.98B$2.38B26.8115,087Positive NewsAMEDAmedisys3.6417 of 5 stars$91.97+0.1%$100.67+9.5%-2.7%$3.01B$2.32B36.5020,000MDPediatrix Medical Group3.1016 of 5 stars$13.30+6.9%$16.25+22.2%+50.3%$1.14B$2.01B-4.355,170Analyst UpgradeGap UpAMNAMN Healthcare Services4.2734 of 5 stars$27.60+2.7%$48.33+75.1%-63.5%$1.05B$3.07B20.003,585CCRNCross Country Healthcare3.0179 of 5 stars$18.19-0.1%$18.54+1.9%-17.3%$598.76M$1.45B-363.732,700ERIEErie Indemnity2.1687 of 5 stars$388.58-0.2%N/A+12.1%$17.95B$3.82B36.356,040Gap DownRYANRyan Specialty3.3742 of 5 stars$64.90+3.8%$75.00+15.6%+51.7%$16.99B$2.39B84.294,350Insider TradeNews Coverage Related Companies and Tools Related Companies LH Alternatives DGX Alternatives DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives ERIE Alternatives RYAN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CRVL) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.